University of Surrey report urges rethink over future water use
How can I reduce my water usage?England needs more hosepipe bans and smart water meters - watchdog
Prof Benjamin Gardner, lead author of the report and professor of psychology at the University of Surrey, said: "Most people don't know how much water they use. "The sector has focused on smart meters, which will raise awareness of water use – but smart meters alone won't cut it."The real challenge is in helping people to better recognise and understand how they use water and supporting them to continue doing their everyday activities, but in a more water-wise way. "To do that, the sector needs to make better use of behavioural science."
'The human factor'
It suggests focussing on issues such as fixing leaks in their homes, taking shorter showers and not flushing toilets so often, and says the water industry should focus on technology to work alongside these changes.Nicci Russell from Waterwise, a non-profit organisation which promotes water efficiency that took part in the study, said: "Research into behaviour helps us design smarter policies, technologies and communications that support people to use water more wisely."We can't afford to ignore the human factor. Water efficiency isn't just about infrastructure - it's about people, choices, habits, and values."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
3 hours ago
- The Independent
New AI tool could speed up skin cancer diagnoses in remote parts of world
A researcher at a Scottish university has developed AI tools that could give people in remote areas of the world access to fast and potentially life-saving skin cancer diagnoses. Tess Watt, the PhD student at Heriot-Watt University in Edinburgh who led the project to develop the technology, said it is intended to enable early detection of skin conditions anywhere in the world, and without the need for direct access to dermatologists. The technology also works without internet access. The system involves a patient taking a photograph of their skin complaint using a small camera attached to a Raspberry Pi device – a cheap, energy-efficient handheld computer that is capable of storing vast amounts of information. The photograph is analysed in real-time using the latest state-of-the-art image classification, comparing it to an enormous dataset of thousands of images stored on the device to reach a diagnosis. The findings are then shared with a local GP service to begin a suitable treatment plan. The project is understood to be the first of its kind to combine AI medical diagnosis with the aim of serving remote communities. Ms Watt explained: ' Healthcare from home is a really important topic at the moment, especially as GP wait times continue to grow. 'If we can empower people to monitor skin conditions from their own homes using AI, we can dramatically reduce delays in diagnosis.' A prototype of the device has already been demonstrated at Heriot-Watt's advanced health and care technologies suite. The research team said the tool is up to 85% accurate in its diagnostic capabilities, but they hope to increase this further by gaining access to more skin lesion datasets, aided by advanced machine tools. Ms Watt is also in talks with NHS Scotland to begin the ethical approval process for testing the technology in real-world clinical settings. 'Hopefully in the next year or two, we'll have a pilot project under way,' she said, noting medical technology often takes years to move from prototype to implementation. She added: 'By the time I finish my PhD, three years from now, I'd love to see something well into the pipeline that's on its way to real-world use.' The university said the long-term vision is to roll the system out first across remote regions of Scotland, before expanding to global areas with limited access to dermatological care. It added the technology could also offer vital support to patients who are infirm or unable to travel, allowing loved ones to assist with capturing and submitting diagnostic images to GPs. Ms Watt's academic supervisor, Dr Christos Chrysoulas, said: 'E-health devices must be engineered to operate independently of external connectivity to ensure continuity of patient service and safety. 'In the event of a network or cloud service failure, such devices must fail safely and maintain all essential clinical operations without functional degradation. 'While auxiliary or non-critical features may become temporarily unavailable, the core diagnostic and even therapeutic capabilities must remain fully operational, in compliance of course with safety and regulatory requirements. 'Ensuring this level of resilience in affordable, low-cost medical devices is the essence of our research, particularly for deployment in resource-limited settings and areas with limited or no connectivity, where uninterrupted patient care must still be guaranteed.' UK Science and Technology Secretary Peter Kyle commented on the research, saying: 'Low-cost technology which could help detect skin cancer early and at home, without even the need for internet access, is an incredible example of AI's potential to break down barriers in healthcare and save lives. 'Promising, first of its kind research like this also demonstrates the crucial role UK innovators can play in improving the lives of people of all backgrounds, wherever they live, and makes clear the value of government investing in research to deliver our plan for change.'
Times
3 hours ago
- Times
When the doctors gave up, ChatGPT found a cure
Move over, Dr Google. The era of Dr GPT has arrived. A friend of mine has for some time been suffering from an escalating histamine intolerance that was actually becoming life-limiting. Histamines, for those who have never had to find out, are chemicals produced by our immune systems or by bacteria that can trigger inflammation and which are present in a dizzying array of food: aged or cured meat, tomatoes, strawberries, many kinds of fish, dairy, aubergine, red wine and so on. Histamine intolerance often involves severe hay fever too, thrown in just for fun. For my friend, dietary changes and various doctors were failing to contain the problem. So, almost out of ideas, my friend's partner took to ChatGPT for troubleshooting. He put in the condition and the symptoms. And within a few minutes, he had some ideas to try: pea sprout powder and nettle tea. Better than nothing, which is what the official medical routes had to offer, and both are known to have anti-histamine properties.
The Guardian
8 hours ago
- The Guardian
The Guardian view on mitochondrial donation: IVF innovation leads to a cautious genetic triumph
Eight babies have been born free of a disease that can lead to terrible suffering and early death, thanks to pioneering scientists in the UK employing a form of genetic engineering that is banned in some countries, including the US and France. Ten years ago, when the government and regulators were considering whether to allow mitochondrial transfer technology, critics warned of 'Frankenstein meddling' that would lead to three-parent children. It's hard now to justify such hostility in the face of the painstaking work carried out by the scientific and medical teams at Newcastle, resulting in these healthy babies and ecstatic families. Mitochondria, like tiny battery packs, supply energy to every cell of the body. Their DNA is handed down in the egg from mother to child. In rare instances, there are genetic mutations, which means the baby may develop mitochondrial disease. About one in 5,000 people is affected by it, making it one of the most common inherited disorders. As the cell batteries fail in various organs, the child can experience a range of symptoms, from muscle weakness to epilepsy, encephalopathy, blindness, hearing loss and diabetes. In severe cases, they die young. There is no cure yet, so the aim is prevention. Women who have some damaged and some healthy mitochondria can have IVF and pre-implantation genetic testing (PGT) to select embryos that are clear of mutations or only slightly affected. The options for women with 100% mutated mitochondria used to be limited to donated eggs or adoption – until parliament changed the rules to allow the technology in 2015 and the Newcastle Fertility Centre was granted a licence by the Human Fertilisation and Embryology Authority to use it in 2017. The process does indeed involve three people. The would-be mother's egg and a donor egg are both fertilised by the man's sperm. The nucleus of the donated egg is removed and replaced by the nucleus of the woman's egg, but its healthy mitochondria remain. This composite egg is inserted into the woman's uterus. The resulting baby's DNA will be 99.9% from the parents and only 0.1% from the donor. Hardly a three-parent child. Yet there are controversies. Some countries will not permit use of the technology because of concerns over human germline genetic modification. The lab-mixed DNA will be passed to future generations, with who knows what consequences. And a question hangs over something called reversal, or reversion. The results of the Newcastle research published in the New England Journal of Medicine show that some of the embryos with healthy donated mitochondria developed mutations somewhere along the line. Mutations formed in 12% of one baby's mitochondria and 16% in another's. That was not enough to affect the babies, who were healthy, but previous work by other scientists has suggested that mutations can increase with time, and nobody yet understands why. The Newcastle scientists and medics have been highly praised for their slow and methodical work. They have brought joy to some families and hope to others. But this is still experimental technology and caution is absolutely valid. And inevitably there are cost issues. People who can afford it will no doubt pay, but the NHS is unlikely to be able to help the rest. Nonetheless, this groundbreaking research must surely be allowed to continue, albeit only in the same careful fashion.
